NALOXONE | NALOXONE | ATC N02AA53 ATC A06AH04 ATC V03AB15 ATC N02AA55 ATC N02AD51 ATC N02AX51
VARIOUS ALKALOID NARCOTIC ANTAGONIST ANTINARCOTIC AGENTS DEPRESSANTS OPIATE ANTAGONISTS RELIEF OF MODERATE TO SEVERE PAIN TREATMENT OF OPIOID DEPENDANCE | INJECTION ORAL SUBLINGUAL BUCCAL INTRAMUSCULAR SUBCUTANEOUS NASAL | Cmax 0.85 NANOMOLAR Tmax 0.81 HOUR VD 110.5 LITER (65 KILOGRAM) PPB 45 PERCENT Cl 89.7 LITER / HOUR (65 KILOGRAM) HT 6.25 HOUR SOLUBILITY SOLUBLE IN WATER | MU-TYPE OPIOID RECEPTOR | Mu-type opioid receptor UNIPROT P35372 OPRM1 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |